Glenmark Pharmaceuticals Ltd in India is considering selling a majority of its 82% stake in Glenmark Life Sciences Ltd in order to reduce its debt load, according to the Mint business daily on Tuesday. According to two people familiar with the....
Cipla Limited, a pharmaceutical company, has announced that it has signed a perpetual licence agreement with Novartis Pharma AG (Switzerland) to manufacture and market Galvus and Galvus combination brands for the treatment of type 2 diabetes...
WuXi STA, a global contract research, development, and manufacturing organisation (CRDMO), has expanded its Changzhou campus with two 2,000 L reactors and a large-scale continuous purification system for peptide manufacturing....
Insempra, a biology-powered firm that enables businesses to create superior goods with nature, has announced the release of its first functional component, a biotechnologically created, 100% natural alpha-Ionone flavour and fragrance ingredient...
With the rise of digital marketing, pharma companies can now reach their target audience more efficiently than ever before.
In order to ensure easy access to medicines at the right time, the Karnataka Price Monitoring Resource Unit (KPMRU) has been monitoring drug availability as the coronavirus disease (Covid-19) has emerged in various variants.
City-based P. B. Siddhartha College of Arts and Science has inked an MoU with pharma major Laurus Labs Ltd. to offer industry skills, internships and career opportunities to its students, said the Principal M. Ramesh...
Indian pharma industry has seen an increase in growth and has reached from Zero to 13 percent of the global market, a report has stated....
CareDx, Inc. and Miromatrix Medical Inc. have announced an exclusive collaboration to advance the next wave of innovation by using fully transplantable human bioengineered organs...
Perfuse Therapeutics, a biopharmaceutical Firm pioneering transformational therapies to treat ischemia-induced ocular diseases, announced that the FDA has approved an Investigational New Drug (IND) application for a phase 1/2a clinical study...